Omakase has participated in a expert panel on “EU Joint HTA of Orphan Drugs and the Likely Local Implications” organised by World Orphan Drug Congress Europe in Sitges.
We have discussed about the potential implications of the EU Joint clinical assement at local level with our colleagues Douglas Foerster (EVERSANA), Timm Volmer (SmartStep Consulting GmbH) and Jiri Hermanek (ExCEEd Orphan).
